- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT03032068
Home Monitoring After Primary Total Knee Arthroplasty
Feasibility of Home Monitoring After Primary Total Knee Arthroplasty
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Ohio
-
Cleveland, Ohio, Vereinigte Staaten, 44195
- Cleveland Clinic Foundation
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Unilateral primary TKA
- Surgery is performed at Cleveland Clinic Main Campus or at Lutheran Hospital
- Patient must reside within 75 miles (driving distance) from Cleveland Clinic Main Campus
- Patient expected to utilize Cleveland Clinic Home Care Services after surgery
Exclusion Criteria:
- Revision or simultaneous bilateral TKA
- English is not the patient's preferred language for healthcare discussions
- Currently participating in any other research study
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Versorgungsforschung
- Zuteilung: N / A
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: At-Home Monitoring
Patients will follow-up in clinic postoperatively at 4, 8, and 12 weeks and their recovery will also be monitored using sensors and communication devices while they are at home after surgery.
|
Patient reported outcomes, functional measures such as the maximum attainable range of motion (AROM) and the number of steps taken will be tracked using sensors worn by the patient.
The AROM sensor values will be verified with range of motion measurements taken using a goniometer during therapy and MD visits.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Overall Reliability of Monitoring Technology, Measured as Proportion of Actual Data Received From the Patient's Home Compared to the Amount of Data Expected (Based on Activities That Were Reported as Completed by Patients) Over the 12 Week Study Period.
Zeitfenster: daily, from the date of discharge until the 12 week postoperative follow-up appointment has occurred
|
The investigators will determine the reliability of the at-home monitoring technology for recording and transmitting data from the patient's home to the healthcare provider. This will be measured for each patient individually and then combined to form an aggregate measurement. Reliability of the technology to collect data was calculated for each patient individually by counting the number of times data (range of motion, TUG test results, VAS Pain score, etc) was received and dividing that number by the number of times data was expected (activities reported as complete by patients). This was then converted into a percentage. Additionally, this number was aggregated by combining the numerators (activities received) for all patients and denominators (activities complete) for all patients and determining the overall reliability of the technology. |
daily, from the date of discharge until the 12 week postoperative follow-up appointment has occurred
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Rehab Compliance
Zeitfenster: Percentage of exercises completed 2-3 times daily, from the date of discharge up to approximately 4 weeks postoperatively when outpatient physical therapy begins
|
Percentage of required at-home therapy exercises completed each session, as well as the total percentage completed during all home therapy sessions
|
Percentage of exercises completed 2-3 times daily, from the date of discharge up to approximately 4 weeks postoperatively when outpatient physical therapy begins
|
|
Change From Preoperative to Postoperative Knee Range of Motion
Zeitfenster: Once preoperatively then postoperatively 2-3 times daily from the date of discharge until the 12 week postoperative follow-up appointment has occurred
|
Change from Preoperative to Postoperative Knee Range of Motion, Knee range of motion is recorded daily using sensors above and below the knee.
Please note: only data from sensors is being reported
|
Once preoperatively then postoperatively 2-3 times daily from the date of discharge until the 12 week postoperative follow-up appointment has occurred
|
|
Change From Preoperative to Postoperative Timed Up and Go Test
Zeitfenster: Once preoperatively then postoperatively 2-3 times daily from the date of discharge until the 12 week postoperative follow-up appointment has occurred
|
Change from Preoperative to Postoperative Timed Up and Go Test.
The time that a patient takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down.
This time was recorded electronically by the patient at home using the tablet.
|
Once preoperatively then postoperatively 2-3 times daily from the date of discharge until the 12 week postoperative follow-up appointment has occurred
|
|
Visual Analog Scale for Pain (Knee-related Pain at Its Worst Over a 24 Hour Period)
Zeitfenster: Once preoperatively then postoperatively 2-3 times daily from the date of discharge until the 12 week postoperative follow-up appointment has occurred
|
Knee-related pain was measured using a visual analog scale with numeric values added to the line.
Zero (0) is the minimum value and 10 is the maximum value.
A score of 0 indicates no pain and a score of 10 indicates the worst pain imaginable.
|
Once preoperatively then postoperatively 2-3 times daily from the date of discharge until the 12 week postoperative follow-up appointment has occurred
|
|
Knee Injury and Osteoarthritis Outcome Score (KOOS) - KOOS Pain
Zeitfenster: Once preoperatively then postoperatively once weekly from the date of discharge until the 12 week follow-up appointment has occurred
|
We will assess KOOS Pain using 9 questions, each response given a point value from 0 to 4. The sum of these points will total between 0 and 36 points.
This score will be normalized to a 100 point scale where 100 means no pain and 0 is extreme pain.
|
Once preoperatively then postoperatively once weekly from the date of discharge until the 12 week follow-up appointment has occurred
|
|
Knee Injury and Osteoarthritis Outcome Score (KOOS) - KOOS PS (Physical Function Short Form)
Zeitfenster: Once preoperatively then postoperatively once weekly from the date of discharge until the 12 week follow-up appointment has occurred
|
We will assess KOOS Function using 7 questions, each response given a point value from 0 to 4. The sum of these points will total between 0 and 28 points.
This total will be normalized to a 100 point scale where 100 means no functional difficulty and 0 is extreme difficulty.
|
Once preoperatively then postoperatively once weekly from the date of discharge until the 12 week follow-up appointment has occurred
|
|
Knee Injury and Osteoarthritis Outcome Score (KOOS) - KOOS QOL
Zeitfenster: Once preoperatively then postoperatively once weekly from the date of discharge until the 12 week follow-up appointment has occurred
|
We will assess KOOS QOL using 4 questions, each response given a point value from 0 to 4. The sum of these points will total between 0 and 16 points, which will then be normalized to a 100 point scale.
One hundred (100) means the knee does not affect quality of life and 0 indicates that the knee is a constant problem affecting quality of life.
|
Once preoperatively then postoperatively once weekly from the date of discharge until the 12 week follow-up appointment has occurred
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Carlos Higuera, MD, Staff Surgeon
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 15-1051
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Arthrose, Knie
-
Gillian HatfieldLes Mills InternationalAktiv, nicht rekrutierendOsteoarthritis Knie und HüfteKanada
-
Anchen Pharmaceuticals, IncNovum Pharmaceutical Research ServicesAbgeschlossenOsteoarthritis des KniesVereinigte Staaten
-
University of North Carolina, Chapel HillCenters for Disease Control and PreventionAnmeldung auf EinladungArthritis | Osteoarthritis KnieVereinigte Staaten
-
University of PaviaAktiv, nicht rekrutierendOsteoarthritis KnieItalien
-
University of JaénAktiv, nicht rekrutierend
-
Robert Jones and Agnes Hunt Orthopaedic and District...Noch keine RekrutierungOsteoarthritis des KniesVereinigtes Königreich
-
Region SkaneGreta and Johan Kock FoundationRekrutierungOsteoarthritis des KniesSchweden
-
Singapore General HospitalAbgeschlossenOsteoarthritis des KniesSingapur
-
University of PaviaNoch keine RekrutierungOsteoarthritis Knie und Hüfte | Endoprothetik der unteren ExtremitätenItalien
-
Pleryon Therapeutics (Hangzhou) LimitedNoch keine RekrutierungOsteoarthritis des KniesAustralien
Klinische Studien zur At-Home Monitoring
-
National University, SingaporeNational University Hospital, SingaporeAbgeschlossen
-
Attralus, Inc.Abgeschlossen
-
Biotronik SE & Co. KGBeendetVorhofflimmern | Herzinsuffizienz (HI)Frankreich, Deutschland, Niederlande, Belgien, Schweden, Vereinigtes Königreich, Tschechien
-
Atea Pharmaceuticals, Inc.ZurückgezogenHepatitis-C-Virus-Infektion | Hepatitis C | Hepatitis C, chronisch | Chronische Hepatitis C | HCV-InfektionBelgien
-
Centre Hospitalier Régional Metz-ThionvilleAbgeschlossenKatarakt | Intraokulares LinsenimplantatFrankreich
-
University of PadovaUniversity Hospital, Padua, ItalyNoch keine Rekrutierung
-
Hôpital le VinatierRekrutierung
-
Groupe Hospitalier Paris Saint JosephBeendet
-
Atea Pharmaceuticals, Inc.AbgeschlossenGesunde FreiwilligenstudieKanada
-
Icahn School of Medicine at Mount SinaiNoch keine Rekrutierung